5 Hot Healthcare Stocks To Buy Now

In this article, we will be taking a look at 5 hot healthcare stocks to buy now. To read our detailed analysis of the healthcare sector, you can go directly to see the 11 Hot Healthcare Stocks To Buy Now.

5. LumiraDx Limited (NASDAQ:LMDX)

Average 3-month Volume as of December 27: 16.46 million

Number of Hedge Fund Holders: 7

LumiraDx Limited (NASDAQ:LMDX) is a healthcare equipment company. It is based in London, United Kingdom.

Seven hedge funds were long LumiraDx Limited (NASDAQ:LMDX) in the third quarter, with a total stake value of $2.9 million.

4. SeaStar Medical Holding Corporation (NASDAQ:ICU)

Average 3-month Volume as of December 27: 17.39 million

Number of Hedge Fund Holders: 4

We saw four hedge funds long SeaStar Medical Holding Corporation (NASDAQ:ICU), in the third quarter, with a total stake value of approximately $2,700.

SeaStar Medical Holding Corporation (NASDAQ:ICU) is a medical device company that develops platform therapy to reduce the consequences of hyperinflammation on vital organs. It is based in Denver, Colorado.

3. Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)

Average 3-month Volume as of December 27: 19.7 million

Number of Hedge Fund Holders: 20

As of November 15, Rahul Sarugaser at Raymond James holds a Market Perform rating on Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) alongside a $2.50 price target.

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) is a specialty chemicals company that develops a platform for cell programming. It is based in Boston, Massachusetts.

A total of 20 hedge funds were long Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) in the third quarter. Their total stake value was $747.9 million.

2. Pfizer Inc. (NYSE:PFE)

Average 3-month Volume as of December 27: 39.5 million

Number of Hedge Fund Holders: 73

Truist Securities’ Robyn Karnauskas reiterated a Buy rating and a $42 price target on Pfizer Inc. (NYSE:PFE) shares on December 4.

Based in New York, Pfizer Inc. (NYSE:PFE) is a pharmaceutical company. It offers medicines and vaccines in several therapeutic areas, such as cardiovascular metabolic, migraine, and women’s health, among more.

Pfizer Inc. (NYSE:PFE) was spotted in the 13F holdings of 73 hedge funds in the third quarter, with a total stake value of $2.4 billion.

1. Avalo Therapeutics, Inc. (NASDAQ:AVTX)

Average 3-month Volume as of December 27: 44.9 million

Number of Hedge Fund Holders: N/A

Avalo Therapeutics, Inc. (NASDAQ:AVTX) is a biotechnology company based in Rockville, Maryland. It develops therapies for treating immune dysregulation.

See also 17 Countries With Better Healthcare Than The United States and 25 Countries With Free Or Universal Healthcare.